Arecor Therapeutics Share Discussion Threads

[stupidboypike] 10/1/2025 11:16

So just 6 months ago this is what they said for the fundraise:-

i. £2.7 million - continue to invest in Arecor research and development with a focus on delivering enhanced injectables and oral-GLP-1 data packages to convert value driving partnering, working capital.
ii. £2.7 million - investment in Tetris Pharma to drive Ogluo® product sales through investment in inventory and in awareness and marketing campaigns in the UK and Germany with the aim to reach cashflow positive in 2026.

So we hope and pray that they haven't spent much of the 2.7m on Tetris. If they haven't then they probably (only?!!) need another £2m for the AT278 trial. My best guess a £3m fund raise at 60p a share in the next month or two. Share price will no doubt tell us the fund raise price in advance of it happening!

Best regards SBP

[supernumerary] 10/1/2025 10:43

Sorry but unsurprised to see this - it always looked a slightly odd fit. Arestat looks increasingly like the only possible source of upside - the insulins will take the time they take, and probably require more money to do it.

[stupidboypike] 10/1/2025 09:01

More bad news this morning. Just went and checked, thankfully, none of the earn out payments were made to Tetris, so the cost of this disaster is (only?!) £2m + whatever was spent on supporting Tetris. Also we hear:-

"These include progression of its novel ultra-concentrated, ultra-rapid acting insulin candidate, AT278, where strategic co-development partnering discussions are progressing at pace,"

Well they were progressing at pace 3 months ago - get on with it Arecor!

An increasingly frustrated SBP

[jonesy100] 10/1/2025 08:50

You can put a positive spin on this in the RNS but they really need to demonstrate they are on top of things this year. 2024 was a real mess with the CFO saga and this is not a great start to 2025.

[stupidboypike] 09/1/2025 07:12

Change of nominated advisor, so fund raise on the way for the next AT278 trial. Not a surprise as I could not see any way for them to get non-exclusive backing from a pharma. Let's hope once this next trial is done (early 2026 if we are lucky?) that they can actually sell AT278 and put some of us shareholders out of our misery.

Best regards SBP

[stupidboypike] 30/12/2024 07:38

Positive enough but no details of financials, unless the upfront is enough for the AT278 trial (I doubt it frankly) it still means that is the big question that needs resolving. Still nice news.

Best regards sbp

[stupidboypike] 13/12/2024 14:12

The share price decline continues and frankly it is difficult to see what would slow that down other than a cracking deal on a trial with the next AT278 trial. How they will get that when they are insisting on non-exclusive is beyond me. I am becoming increasingly frustrated at Arecor. If I had any sense I would probably get rid of half my holding, but it does appear that in the fullness of time it could come good, so I am hanging on. May well regret that!!!

Best regards SBP

[stupidboypike] 12/11/2024 11:32

Have just added a new note to the header:-
hxxps://www.trinitydelta.org/research-notes/at220-sales-building-momentum/

Nothing very exciting, slight slip in revenue timescales.

Best regards SBP

[stupidboypike] 23/10/2024 08:54

Jonesy,

Yes I agree, despite my huge frustration over the share price and the way the financing/PR has been managed over the last few months, I do think Arecor is a winner. The technology clearly delivers something unique into a market worth many billions. I have a reasonable holding and don't plan on parting with any of them until a decent portion of that value comes out. A half decent deal on the next trial with AT278 could completely transform the market perception of Arecor. Here's hoping!

Best regards SBP

[jonesy100] 22/10/2024 18:53

I have watched the presentation now. Quite impressed overall and gently topping up. If the comments about positive news flow through q4 and into 2025 turn out to be right, then we may have a bottom.

[stupidboypike] 16/10/2024 16:10

The two "sells" of 9850 shares were a sale and purchase into my isa. (Nice to see the share price nudging up for once.)

Best regards SBP

[stupidboypike] 04/10/2024 01:55

I worry that in hanging on for the very best deal, the share price will drop so low (even lower than now!!) and make us vulnerable to a cheap takeover.

Best regards SBP

[stupidboypike] 04/10/2024 01:53

Sarah did say that she was determined that partner discussions on next trial of At278 were non-exclusive. I’m trying to get my head around what benefit a pump manufacturer would get financing the trial if their competitors could still buy a successful result. Anyone got any thoughts?


Best regards SBP

[jonesy100] 03/10/2024 17:10

Thanks SBP. I missed the event. My concern remains the same - the market is giving its answer every day and I worry what we are missing still about long term value

[stupidboypike] 03/10/2024 14:56

In case anyone is interested, my summary of the answer was "maybe, we don't know"

Best regards SBP

[stupidboypike] 03/10/2024 14:08

If anyone is on the webinar, I have just asked the following question:

"What plans do the company have in light of the fact that the recent fund raise only raised enough cash for 24 months. As we have seen by the share price reaction, the market hates a company that is losing money and in constant need of funds. Is it hoped that a deal with AT278 will produce the long awaited "value inflexion point" that will shore up the cashflow within that 24 month window?"

If anyone else is on the webinar and would like the answer please vote it up.

Best regards SBP

[stupidboypike] 26/9/2024 06:28

jonesy:-
"The Group has been actively engaged in a search for a new Chief Financial Officer (CFO) and had identified and progressed a preferred candidate. Due to circumstances beyond Arecor's control that candidate is no longer available. The process remains underway and the Group intends to appoint an interim CFO as soon as possible"

Best regards SBP

[jonesy100] 26/9/2024 06:20

Results look ok but high cash burn is a worry. Will try to listen to presentation. Where on earth is the new cfo.

[jonesy100] 24/9/2024 07:44

There is an AREC results presentation being hosted by LSE on Thursday. Maybe we will find out then whether there is something badly wrong.

[stupidboypike] 11/9/2024 09:08

Data looks good. As I said, in theory AT278 should be very valuable. Time to realise that value by way of a deal.

Best regards SBP

[stupidboypike] 04/9/2024 17:15

c3479z, that's slightly reassuring from an Arecor point of view. In theory AT278 should be very valuable as far as I can see, it's just hard to believe it when the company is currently valued at £30m (about the same as the cash it has raised over the last 2 years). I'll go back to quietly sulking now!!! Best regards SBP

[c3479z] 04/9/2024 16:32

they've sponsored about 6 projects and universities around the world to research smart insulin including China and Australian outfits but no product perfected or in trials, to my knowledge.
seems NOvo had a smart insulin in phase1 trials in last 5 yr but it's gone quiet so suspect it didn't work or performance was suboptimal and too slow to respond or turn itself off when the glucose dropped. Though the project still appears in their website pipeline.
LLy also researching glucose responsive insulin.

will believe a smart insulin when I see it.

[stupidboypike] 04/9/2024 14:49

Certainly progress is being made with smart insulin which would render non-smart insulin obsolete:-


This is probably still years away from being available, but so much more of a reason to get a deal (virtually any deal!) done on AT278 and AT247 while they still have (hopefully) some value.

Best regards SBP

[jonesy100] 04/9/2024 14:44

When there is a steady fall and a motivated seller, I always get very concerned too in case we are missing something much bigger. Absolutely agree they need new FD PDQ and clarity on their strategy. The delay on appointing one is a further source of nerves.

[stupidboypike] 04/9/2024 08:07

This share feels very poorly! There really doesn't seem much to look forward to since they told us they need to do ANOTHER trial with AT278. Hopefully they get a hard nosed financial director in who gets a grip! (continuing to hold but very far from happy!)

Best regards SBP